![New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827815001336-gr1.jpg)
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect
![Frontiers | Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles Frontiers | Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles](https://www.frontiersin.org/files/Articles/411880/fphar-09-01283-HTML-r2/image_m/fphar-09-01283-g001.jpg)
Frontiers | Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
![The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models | Lipids in Health and Disease | Full Text The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models | Lipids in Health and Disease | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12944-020-01334-3/MediaObjects/12944_2020_1334_Fig8_HTML.png)
The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models | Lipids in Health and Disease | Full Text
The canadian multicenter doubleâ•'blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
![Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00007/asset/images/medium/mp2c00007_0017.gif)
Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics
![Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels | American Journal of Physiology-Gastrointestinal and Liver Physiology Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels | American Journal of Physiology-Gastrointestinal and Liver Physiology](https://journals.physiology.org/cms/10.1152/ajpgi.00125.2021/asset/images/medium/gi-00125-2021r01.png)
Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels | American Journal of Physiology-Gastrointestinal and Liver Physiology
![Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study | Scientific Reports Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-53999-1/MediaObjects/41598_2019_53999_Fig1_HTML.png)
Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study | Scientific Reports
![Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway | Molecular Pharmacology Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/91/2/110/F1.large.jpg)
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway | Molecular Pharmacology
![Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. - Abstract - Europe PMC Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6817734/bin/mv-v25-610-f1.jpg)
Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. - Abstract - Europe PMC
![Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin - Nano Market Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin - Nano Market](https://nano.market/wp-content/uploads/2021/10/47517-metabolic-and-immunomodulatory-control-of-type-1-diabetes-via-orally-delivered-bile-acid-polymer-nanocarriers-of-insulin-or-rapamycin.png)
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin - Nano Market
![New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827815001336-gr2.jpg)
New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond - ScienceDirect
![Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans](https://static-02.hindawi.com/articles/grp/volume-2012/159438/figures/159438.fig.001.jpg)